Pesquisas alternativas:
does » dos (Expandir a Pesquisa)
ther » them (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
liver » livr (Expandir a Pesquisa), lifer (Expandir a Pesquisa), liner (Expandir a Pesquisa)
live » liv (Expandir a Pesquisa), life (Expandir a Pesquisa), line (Expandir a Pesquisa)
does » dos (Expandir a Pesquisa)
ther » them (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
liver » livr (Expandir a Pesquisa), lifer (Expandir a Pesquisa), liner (Expandir a Pesquisa)
live » liv (Expandir a Pesquisa), life (Expandir a Pesquisa), line (Expandir a Pesquisa)
1
“...Identification of novel molecular targets is critical in development of new and efficient cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Canal, Clinton E., Morgan, Drake, Felsing, Daniel, Kondabolu, Krishnakanth, Rowland, Neil E., Robertson, Kimberly L., Sakhuja, Rajeev, Booth, Raymond G.
Publicado em 2014
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Klymenko, Tetyana, Brandenburg, Martin, Morrow, Christopher, Dive, Caroline, Makin, Guy
Publicado em 2011
“..., and leads to pleiotropic drug resistance, mediated by Bcl-2 family proteins. ABT-737 is a novel small...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)
“... for Parkinson’s disease (PD). A critical dose level above which a better benefit-to-harm ratio exists has not been...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“..., BMI, drug dose and time from drug intake were recorded. RESULTS: All patients had a measurable...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... a novel mechanism for the control of disulfide-based drug release rates. Therapy experiments...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Lawrance, Ian Craig
Publicado em 2010
“..., the control of the inflammation is even more effective. Unfortunately, resistant DC does occur and can...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Livingston, Paula, Strouse, Bryan, Perry, Haley, Borjigin, Mandula, Bialk, Pawel, Kmiec, Eric B.
Publicado em 2012
“... to define the basis for drug resistance in human cells. A troubling outcome of the gene-editing reaction...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Kosilov, Kirill Vladimirovich, Loparev, Sergey, Kuzina, Irina, Shakirova, Olga, Zhuravskaya, Nataliya, Lobodenko, Alexandra
Publicado no Ther Adv Urol (2016)
“... in antimuscarinic (AM) drug treatment. BACKGROUND: The prevalence of urge urinary incontinence (UUI) is an average...”Publicado no Ther Adv Urol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Siore, Amsel M., Parker, Richard E., Cuppels, Chris, Thorn, Natalie, Hansen, Jason M., Stecenko, Arlene A., Brigham, Kenneth L.
Publicado em 2012
“... and cellular responses of liver and lung to endotoxemia with and without the drugs. Endotoxemia caused...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“... response, lower the risk that drug resistance will develop, and reduce morbidity and mortality. Little...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Zhang, Huixia, Wu, Xiaohui, Naraharisetti, Suresh Babu, Chung, Francisco, Whittington, Dale, Mirfazaelian, Ahmad, Unadkat, Jashvant D.
Publicado em 2009
“... be reproduced in a representative non-human primate model, Macaca nemestrina (J Pharmacol Exp Ther 329:1016–1022...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Djobet, M. P. Ngogang, Singhe, David, Lohoue, Julienne, Kuaban, Christopher, Ngogang, Jeanne, Tambo, Ernest
Publicado no AIDS Res Ther (2017)
“.... ARVs drugs samples included Nevirapine, Efavirenz, and fixed dose combinations of Zidovudine...”Publicado no AIDS Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“.... Longitudinal prescription data can be used as a measure of drug supply and are particularly useful to identify...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Haj, Christeene G., Sumariwalla, Percy F., Hanuš, Lumír, Kogan, Natalya M., Yektin, Zhana, Mechoulam, Raphael, Feldmann, Mark, Gallily, Ruth
Publicado no J Pharmacol Exp Ther (2015)
“... potential novel drug for rheumatoid arthritis and other inflammatory diseases....”Publicado no J Pharmacol Exp Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Kaszas, Krisztian, Keller, Jason M., Coddou, Claudio, Mishra, Santosh K., Hoon, Mark A., Stojilkovic, Stanko, Jacobson, Kenneth A., Iadarola, Michael J.
Publicado em 2012
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Metcalf, Cameron S., Klein, Brian D., McDougle, Daniel R., Zhang, Liuyin, Smith, Misty D., Bulaj, Grzegorz, White, H. Steve
Publicado no J Pharmacol Exp Ther (2015)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Vornov, James J., Wozniak, Krystyna M., Wu, Ying, Rojas, Camilo, Rais, Rana, Slusher, Barbara S.
Publicado em 2013
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Goláň, Lubor, Goker-Alpan, Ozlem, Holida, Myrl, Kantola, Ikka, Klopotowski, Mariusz, Kuusisto, Johanna, Linhart, Aleš, Musial, Jacek, Nicholls, Kathleen, Gonzalez-Rodriguez, Derlis, Sharma, Reena, Vujkovac, Bojan, Chang, Peter, Wijatyk, Anna
Publicado no Drug Des Devel Ther (2015)
“.... Secondary endpoints included cardiac (peak oxygen consumption, 6-minute walk test, Minnesota Living...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Wang, Xue Yan, Lim-Jurado, Margaret, Prepageran, Narayanan, Tantilipikorn, Pongsakorn, Wang, De Yun
Publicado no Ther Clin Risk Manag (2016)
“... that it has very low potential for drug–drug interactions, and does not require dose adjustment in renal...”Publicado no Ther Clin Risk Manag (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo